{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Medi Caps Ltd
Medi Caps Ltd is Rated Strong Sell
Medi Caps Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 Feb 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 18 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Medi Caps Ltd is Rated Strong Sell
Medi Caps Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 Feb 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 27 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Medi Caps Ltd Falls 9.72%: 2 Key Factors Behind the Weekly Decline
Medi Caps Ltd experienced a challenging week ending 22 May 2026, with its stock price declining by 9.72% from Rs.29.01 to Rs.26.19, significantly underperforming the Sensex, which rose 0.50% over the same period. Despite posting its highest quarterly profit after tax and earnings per share, the company’s operational struggles and margin pressures weighed heavily on investor sentiment, resulting in sustained selling pressure throughout the week.
Are Medi Caps Ltd latest results good or bad?
Medi Caps Ltd's latest results show a net profit of ₹3.04 crores, up 76.74% year-on-year, but this was largely due to exceptional income, as the company faced a significant revenue decline of 50.50% and negative operating margins. Overall, the financial performance indicates serious operational challenges that need addressing.
Medi Caps Ltd Reports Flat Quarterly Performance Amid Margin Pressures
Medi Caps Ltd reported a flat financial performance for the quarter ended March 2026, marking a notable improvement from the previous negative trend. Despite a significant contraction in net sales and operating profitability, the company achieved its highest quarterly PAT and EPS to date, signalling a tentative stabilisation in earnings amid ongoing challenges in the pharmaceuticals sector.
Medi Caps Q4 FY26: Profit Surge Masks Deepening Operational Crisis
Medi Caps Ltd., India's second-largest manufacturer of empty hard gelatine capsules, reported a net profit of ₹3.04 crores for Q4 FY26, marking a dramatic 76.74% year-on-year increase from ₹1.72 crores in Q4 FY25. However, this apparent profitability triumph conceals a troubling reality: the company's core operations continue to deteriorate, with revenues collapsing 50.50% year-on-year to just ₹3.45 crores, whilst operating losses deepened alarmingly. The stock has reacted negatively to the broader operational distress, declining 1.41% following the results announcement.
When is the next results date for Medi Caps Ltd?
The next results date for Medi Caps Ltd is 21 May 2026.
Medi Caps Ltd is Rated Strong Sell
Medi Caps Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 Feb 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 12 May 2026, providing investors with the latest insights into its performance and outlook.
Medi Caps Ltd is Rated Strong Sell
Medi Caps Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 Feb 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and overall market stance.
Medi Caps Ltd is Rated Strong Sell
Medi Caps Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 Feb 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 10 April 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.
Medi Caps Ltd Stock Falls to 52-Week Low of Rs.21 Amidst Continued Weakness
Medi Caps Ltd, a player in the Pharmaceuticals & Biotechnology sector, recorded a new 52-week low of Rs.21 today, marking a significant decline in its stock price amid a broader market downturn and persistent company-specific headwinds.
Medi Caps Ltd Stock Falls to 52-Week Low of Rs.21.02 Amidst Continued Financial Struggles
Medi Caps Ltd, a player in the Pharmaceuticals & Biotechnology sector, recorded a new 52-week low of Rs.21.02 today, marking a significant decline in its stock price amid ongoing financial difficulties and subdued operational performance.
Medi Caps Ltd Stock Falls to 52-Week Low of Rs.21.56 Amidst Continued Weakness
Medi Caps Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a fresh 52-week low of Rs.21.56 today, marking a significant decline amid a sustained downward trend. The stock has underperformed its sector and benchmark indices, reflecting ongoing financial pressures and subdued market sentiment.
Medi Caps Ltd Falls 8.84%: Four Key Factors Driving the Steep Decline
Medi Caps Ltd’s stock declined sharply by 8.84% over the week ending 13 Feb 2026, closing at Rs.22.18 from Rs.24.33, significantly underperforming the Sensex which fell only 0.54% during the same period. The stock hit successive 52-week lows amid deteriorating financial results, weak profitability, and sustained bearish momentum, contrasting with the broader market’s relative resilience.
Medi Caps Ltd Stock Falls to 52-Week Low of Rs.22 Amidst Continued Downtrend
Medi Caps Ltd, a company operating in the Pharmaceuticals & Biotechnology sector, has witnessed its stock price decline to a fresh 52-week low of Rs.22 today, marking a significant downturn amid a broader market environment that remains mixed. This new low reflects ongoing pressures on the company’s financial performance and market valuation.
Are Medi Caps Ltd latest results good or bad?
Medi Caps Ltd's latest results are concerning, showing a 56.61% year-on-year decline in net sales and a net loss of ₹0.77 crores, indicating significant operational challenges despite a sequential revenue increase. The company's financial health is under stress, necessitating urgent action to improve performance and regain investor confidence.
Medi Caps Ltd Stock Falls to 52-Week Low of Rs.22.99 Amidst Continued Weak Performance
Medi Caps Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a fresh 52-week low of Rs.22.99 today, marking a significant decline in its stock price amid ongoing financial pressures and subdued market performance.
Are Medi Caps Ltd latest results good or bad?
Medi Caps Ltd's latest Q2 FY26 results are poor, showing a net loss of ₹1.82 crores and a 75.63% decline in revenue year-on-year, indicating severe operational challenges and inefficiencies. The company faces significant structural issues, with high employee costs and a negative five-year sales growth rate.
Medi Caps Q3 FY26: Losses Deepen as Revenue Struggles Continue
Medi Caps Ltd., one of India's established manufacturers of empty hard gelatine capsules, posted a net loss of ₹0.77 crores in Q3 FY26, marking its third consecutive quarter of losses. The Madhya Pradesh-based pharmaceutical company, with a market capitalisation of ₹31.00 crores, continues to face severe operational headwinds as revenue declined 56.61% year-on-year to ₹4.30 crores during the quarter ended December 2025.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
